Search





Search





Markets
/
Stocks
/
arqt
/

Arcutis Biotherapeutics Inc

ARQT

Add to Watchlist

26.860USD

-1.130-4.04%

Close 07-31 16:00（ET）Quotes delayed by 15 min

3.36BMarket Cap

LossP/E TTM

Arcutis Biotherapeutics Inc

26.860

-1.130-4.04%

Financial Summary Income Statement Balance Sheet Cash Flow Statement

Overview

Financials

Discussions

Analysis

Company

Financial Summary Income Statement Balance Sheet Cash Flow Statement

ARQT Cash Flow Statement

You can access the annual and quarterly cash flow statements of Arcutis Biotherapeutics Inc to evaluate its financial soundness and stability.

Quarterly

Quarterly+Annual

Quarterly

Annual

YOY

Hide blank rows

FY2026Q1

FY2025Q4

FY2025Q3

FY2025Q2

FY2025Q1

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021Q4

FY2021Q3

FY2021Q2

FY2021Q1

FY2020Q4

FY2020Q3

FY2020Q2

FY2020Q1

FY2019Q4

FY2019Q3

FY2019Q2

FY2019Q1

FY2018Q4

FY2018Q3

Operating cash flows (indirect method)

Cash flow from continuing operating activities

107.37%2.24M

3600.67%26.18M

94.94%-1.75M

100.72%324.00K

3.87%-30.38M

98.67%-748.00K

21.13%-34.69M

32.14%-45.12M

60.67%-31.60M

20.86%-56.24M

35.03%-43.98M

-7.27%-66.48M

-41.02%-80.34M

-37.43%-71.06M

-65.58%-67.69M

-72.98%-61.98M

-23.31%-56.98M

-58.76%-51.71M

-21.35%-40.88M

-39.09%-35.83M

-119.91%-46.20M

-93.91%-32.57M

-211.64%-33.69M

-212.52%-25.76M

-197.00%-21.01M

-187.72%-16.80M

-285.14%-10.81M

---8.24M

---7.07M

---5.84M

---2.81M

Net income from continuing operations

54.93%-11.29M

261.24%17.39M

117.84%7.41M

69.64%-15.89M

29.17%-25.06M

83.72%-10.79M

7.21%-41.54M

26.28%-52.33M

55.83%-35.38M

7.96%-66.28M

58.44%-44.77M

-5.32%-70.99M

-24.53%-80.10M

-0.97%-72.02M

-89.03%-107.71M

-60.46%-67.41M

-78.47%-64.32M

-109.48%-71.33M

-49.15%-56.98M

-18.63%-42.01M

-28.66%-36.04M

-170.92%-34.05M

-163.82%-38.20M

-327.17%-35.41M

-320.74%-28.01M

-124.39%-12.57M

-88.68%-14.48M

---8.29M

---6.66M

---5.60M

---7.67M

Operating gains losses

-82.06%562.00K

22.93%563.00K

-60.75%562.00K

60.40%563.00K

774.86%3.13M

18.96%458.00K

270.03%1.43M

-9.07%351.00K

-1.38%358.00K

10.95%385.00K

37.23%387.00K

149.03%386.00K

142.00%363.00K

155.15%347.00K

143.10%282.00K

49.04%155.00K

53.06%150.00K

288.57%136.00K

286.67%116.00K

246.67%104.00K

262.96%98.00K

45.83%35.00K

-31.82%30.00K

50.00%30.00K

440.00%27.00K

--24.00K

--44.00K

--20.00K

--5.00K

----

Other non-cash items

104.28%32.00K

103.24%32.00K

83.13%-268.00K

73.28%-611.00K

54.05%-748.00K

28.23%-989.00K

-10.27%-1.59M

-31.74%-2.29M

21.50%-1.63M

39.03%-1.38M

-104.98%-1.44M

-594.59%-1.74M

-397.56%-2.07M

-335.42%-2.26M

2250.24%28.91M

-59.98%351.00K

0.14%697.00K

88.24%960.00K

640.96%1.23M

849.57%877.00K

551.95%696.00K

1207.69%510.00K

216.08%166.00K

14.60%-117.00K

-52.48%-154.00K

378.57%39.00K

-104.77%-143.00K

---137.00K

---101.00K

---14.00K

--3.00M

Change in working capital

110.11%1.79M

-48.44%-2.33M

-424.29%-19.94M

220.18%5.13M

-225.01%-17.69M

-481.27%-1.57M

58.56%-3.80M

25.48%-4.27M

39.57%-5.44M

105.54%411.00K

-844.53%-9.18M

-60.30%-5.73M

-2029.08%-9.01M

-157.76%-7.41M

-86.86%1.23M

-517.29%-3.57M

97.83%-423.00K

832.59%12.84M

356.57%9.39M

-88.87%856.00K

-416.91%-19.46M

63.09%-1.75M

-43.13%2.06M

30656.00%7.69M

1650.51%6.14M

-1601.43%-4.75M

99.17%3.62M

--25.00K

---396.00K

---279.00K

--1.81M

-Change in receivables

115.00%1.85M

-120.25%-31.11M

49.25%-8.43M

-310.89%-21.27M

-8.83%-12.35M

-121.06%-14.13M

-651.54%-16.61M

-16.65%-5.18M

-163.21%-11.35M

-6.02%-6.39M

9.09%-2.21M

---4.44M

---4.31M

---6.03M

---2.43M

----

-Change in inventory

-647.26%-14.58M

98.11%-5.00K

-1064.16%-5.89M

181.83%518.00K

-1626.55%-1.95M

-134.02%-265.00K

117.77%611.00K

67.08%-633.00K

89.10%-113.00K

124.29%779.00K

20.15%-3.44M

---1.92M

---1.04M

---3.21M

---4.31M

----

-Change in prepaid expenses

-257.34%-11.73M

-1816.67%-1.26M

58.60%-1.76M

298.25%4.30M

-159.26%-3.28M

-104.50%-66.00K

50.53%-4.25M

-335.50%-2.17M

329.32%5.54M

24.98%1.47M

-3680.42%-8.59M

-55.27%921.00K

---2.42M

196.62%1.17M

-93.50%240.00K

-27.96%2.06M

100.00%0.00

60.11%-1.21M

1319.23%3.69M

510.68%2.86M

-1054.33%-12.66M

-60.50%-3.04M

54.76%260.00K

137.11%468.00K

-248.25%-1.10M

-772.34%-1.90M

148.70%168.00K

---1.26M

---315.00K

--282.00K

---345.00K

-Change in other current assets

----

--0.00

100.00%0.00

--0.00

---47.00K

----

--0.00

Cash from non-recurring investing activities

Cash from operating activities

107.37%2.24M

3600.67%26.18M

94.94%-1.75M

100.72%324.00K

3.87%-30.38M

98.67%-748.00K

21.13%-34.69M

32.14%-45.12M

60.67%-31.60M

20.86%-56.24M

35.03%-43.98M

-7.27%-66.48M

-41.02%-80.34M

-37.43%-71.06M

-65.58%-67.69M

-72.98%-61.98M

-23.31%-56.98M

-58.76%-51.71M

-21.35%-40.88M

-39.09%-35.83M

-119.91%-46.20M

-93.91%-32.57M

-211.64%-33.69M

-212.52%-25.76M

-197.00%-21.01M

-187.72%-16.80M

-285.14%-10.81M

---8.24M

---7.07M

---5.84M

---2.81M

Investing cash flow

Net cash from continuing investing activities

-100.00%0.00

--10.08M

--608.00K

83233.33%5.00M

123.44%143.00K

-100.00%0.00

-95.12%6.00K

-99.72%64.00K

245.00%276.00K

-33.87%82.00K

-52.87%123.00K

16656.20%22.96M

86.05%80.00K

-77.62%124.00K

70.59%261.00K

24.55%137.00K

152.94%43.00K

1251.22%554.00K

131.82%153.00K

279.31%110.00K

-59.52%17.00K

-77.60%41.00K

--66.00K

--29.00K

--42.00K

--183.00K

----

--0.00

Capital expenditures

-100.00%0.00

--10.08M

--608.00K

83233.33%5.00M

123.44%143.00K

-100.00%0.00

-95.12%6.00K

-99.72%64.00K

245.00%276.00K

-33.87%82.00K

-52.87%123.00K

16656.20%22.96M

86.05%80.00K

-77.62%124.00K

70.59%261.00K

24.55%137.00K

152.94%43.00K

1251.22%554.00K

131.82%153.00K

279.31%110.00K

-59.52%17.00K

-77.60%41.00K

--66.00K

--29.00K

--42.00K

--183.00K

----

--0.00

Net cash flow from disposal of fixed assets

-100.00%0.00

--0.00

-100.00%0.00

--78.00K

--608.00K

-100.00%0.00

123.44%143.00K

-100.00%0.00

-95.12%6.00K

966.67%64.00K

245.00%276.00K

-33.87%82.00K

-52.87%123.00K

-95.62%6.00K

86.05%80.00K

-77.62%124.00K

70.59%261.00K

24.55%137.00K

152.94%43.00K

1251.22%554.00K

131.82%153.00K

279.31%110.00K

-59.52%17.00K

-77.60%41.00K

--66.00K

--29.00K

--42.00K

--183.00K

----

--0.00

Net cash flow from intangible asset transactions

----

-100.00%0.00

--0.00

--10.00M

----

--5.00M

----

--0.00

--22.95M

----

Net cash flow from investment products

-191.70%-11.33M

-185.71%-34.18M

-129.73%-25.25M

144.26%27.50M

143.06%12.36M

164.13%39.88M

86.17%84.92M

-169.51%-62.14M

-126.61%-28.70M

-246.91%-62.18M

126.17%45.61M

69.81%89.39M

599.26%107.83M

78.13%42.32M

-4931.10%-174.31M

131.93%52.65M

-75.35%15.42M

131.37%23.76M

103.94%3.61M

-2793.17%-164.88M

408.36%62.55M

-110.78%-75.74M

-531.80%-91.60M

390.14%6.12M

-123.23%-20.29M

-211.59%-35.93M

--21.21M

---2.11M

---9.09M

---11.53M

--0.00

Net cash flow from other investing activities

----

--0.00

----

Cash from non-current investing activities

Net cash flow from investing activities

-196.44%-11.33M

-198.00%-34.18M

-129.78%-25.25M

128.04%17.42M

140.95%11.75M

156.08%34.88M

86.12%84.78M

-169.72%-62.14M

-126.63%-28.70M

-247.36%-62.19M

123.09%45.55M

69.54%89.12M

604.39%107.75M

79.59%42.20M

-5783.15%-197.26M

131.87%52.56M

-75.33%15.30M

130.96%23.50M

103.78%3.47M

-2801.38%-164.92M

405.01%62.00M

-110.82%-75.89M

-532.91%-91.71M

383.69%6.11M

-119.27%-20.33M

-212.17%-36.00M

--21.18M

---2.15M

---9.27M

---11.53M

--0.00

Financing cash flow

Cash flow from continuous financing activities

170.13%1.07M

103.82%3.72M

274.62%1.48M

-5.15%1.38M

-99.76%395.00K

-198.11%-97.41M

-54.56%394.00K

36.36%1.46M

161664.00%161.76M

10221.10%99.29M

-99.70%867.00K

-5.66%1.07M

-99.32%100.00K

-98.68%962.00K

452263.49%284.99M

-4.80%1.13M

-92.92%14.72M

-43.67%72.88M

114.42%63.00K

284.47%1.19M

23.05%207.81M

39.19%129.38M

-2085.00%-437.00K

83.93%309.00K

--168.89M

--92.95M

-100.04%-20.00K

--168.00K

--0.00

--55.06M

Net cash flow from debt Issuance/repayment

----

100.00%0.00

----

---100.00M

----

--0.00

-100.00%0.00

----

-100.00%0.00

--125.00M

--0.00

----

--73.99M

----

--0.00

----

Net cash flow from common stock issuance/repurchase

----

-0.66%1.06M

--0.00

103.24%1.32M

-100.00%0.00

-98.93%1.06M

--0.00

-27.32%649.00K

161582.00%161.68M

10373.89%99.08M

-100.00%0.00

-8.41%893.00K

-99.31%100.00K

159.89%946.00K

--161.59M

103.97%975.00K

-93.03%14.46M

-99.72%364.00K

--0.00

1227.78%478.00K

22.85%207.49M

1429788.89%128.69M

-100.00%0.00

--36.00K

--168.89M

--9.00K

-39.31%88.00K

--0.00

--145.00K

Net cash flow from preferred stock issuance/repurchase

----

--94.24M

-100.00%0.00

----

--54.91M

Proceeds from stock option exercised by employees

170.13%1.07M

74.75%2.67M

274.62%1.48M

-92.43%61.00K

381.71%395.00K

640.29%1.52M

-54.56%394.00K

363.22%806.00K

--82.00K

1187.50%206.00K

48.46%867.00K

11.54%174.00K

----

-90.42%16.00K

826.98%584.00K

-78.03%156.00K

-20.00%260.00K

-23.74%167.00K

85.29%63.00K

160.07%710.00K

--325.00K

--219.00K

--34.00K

62.50%273.00K

----

--168.00K

----

Net cash flow from other financing activities

----

--0.00

----

--0.00

----

100.00%0.00

---2.19M

----

-447.56%-1.64M

100.00%0.00

----

136.43%471.00K

-336.11%-471.00K

----

---1.29M

---108.00K

----

Net cash from non-recurrent financing activities

Net cash from financing activities

170.13%1.07M

103.82%3.72M

274.62%1.48M

-5.15%1.38M

-99.76%395.00K

-198.11%-97.41M

-54.56%394.00K

36.36%1.46M

161664.00%161.76M

10221.10%99.29M

-99.70%867.00K

-5.66%1.07M

-99.32%100.00K

-98.68%962.00K

452263.49%284.99M

-4.80%1.13M

-92.92%14.72M

-43.67%72.88M

114.42%63.00K

284.47%1.19M

23.05%207.81M

39.19%129.38M

-2085.00%-437.00K

83.93%309.00K

--168.89M

--92.95M

-100.04%-20.00K

--168.00K

--0.00

--55.06M

Net cash flow

Beginning cash balance

-39.94%43.22M

-64.99%47.43M

-13.95%73.05M

-71.83%53.72M

-19.45%71.95M

24.98%135.47M

-19.95%84.89M

131.65%190.71M

62.78%89.32M

30.95%108.40M

69.00%106.04M

15.91%82.33M

-44.00%54.88M

55.25%82.78M

-30.80%62.74M

-75.53%71.03M

47.08%97.99M

16.66%53.32M

-47.15%90.67M

52.04%290.23M

5.19%66.62M

97.21%45.71M

1237.80%171.55M

728.17%190.89M

60.78%63.34M

-59.17%23.18M

184.07%12.82M

--23.05M

--39.39M

--56.76M

--4.51M

Current period cash flow changes

55.32%-8.14M

93.37%-4.21M

-150.65%-25.62M

118.26%19.33M

-117.98%-18.23M

-233.02%-63.52M

2045.99%50.58M

-546.36%-105.83M

269.30%101.39M

31.64%-19.07M

-88.23%2.36M

386.20%23.71M

201.83%27.45M

-162.46%-27.90M

153.63%20.03M

95.85%-8.28M

-112.06%-26.96M

113.56%44.67M

70.32%-37.35M

-931.49%-199.56M

75.30%223.61M

-47.91%20.92M

-1315.37%-125.84M

-89.18%-19.35M

880.45%127.56M

331.20%40.16M

-80.18%10.35M

---10.23M

---16.34M

---17.37M

--52.25M

Effect of exchange rate changes

-3075.00%-119.00K

125.21%59.00K

-196.94%-95.00K

869.23%200.00K

105.48%4.00K

-444.12%-234.00K

230.67%98.00K

-388.89%-26.00K

-40.38%-73.00K

--68.00K

---75.00K

--9.00K

---52.00K

----

Ending cash balance

-34.72%35.07M

-39.94%43.22M

-64.99%47.43M

-13.95%73.05M

-71.83%53.72M

-19.45%71.95M

24.98%135.47M

-19.95%84.89M

131.65%190.71M

62.78%89.32M

30.95%108.40M

69.00%106.04M

15.91%82.33M

-44.00%54.88M

55.25%82.78M

-30.80%62.74M

-75.53%71.03M

47.08%97.99M

16.66%53.32M

-47.15%90.67M

52.04%290.23M

5.19%66.62M

97.21%45.71M

1237.80%171.55M

728.17%190.89M

60.78%63.34M

-59.17%23.18M

--12.82M

--23.05M

--39.39M

--56.76M

Free cash flow

107.23%2.24M

555.55%26.18M

94.96%-1.75M

78.38%-9.75M

1.95%-30.99M

89.78%-5.75M

20.92%-34.83M

32.42%-45.12M

60.71%-31.60M

20.98%-56.25M

51.41%-44.05M

-7.57%-66.76M

-40.85%-80.43M

-36.98%-71.19M

-120.99%-90.65M

-72.99%-62.06M

-22.12%-57.10M

-58.81%-51.97M

-21.36%-41.02M

-39.17%-35.87M

-122.11%-46.76M

-94.06%-32.72M

-211.82%-33.80M

-211.14%-25.78M

-190.08%-21.05M

-188.85%-16.86M

-286.18%-10.84M

---8.29M

---7.26M

---5.84M

---2.81M

Currency unit

--USD

Audit opinions

----

FAQs

What is operating cash flow?



Operating cash flow is the cash generated or used by a company's core business operations. It adjusts net income for non-cash items and working capital changes, such as depreciation, receivables, inventory, and payables. Strong operating cash flow can indicate that the business is converting sales and earnings into real cash.

How Much Operating Cash Flow Did Arcutis Biotherapeutics Inc Generate?



Arcutis Biotherapeutics Inc generated -5.62M in operating cash flow in fiscal 2025, reflecting cash generated from its core business operations.

How Did Arcutis Biotherapeutics Inc's Operating Cash Flow Change Year Over Year?



Arcutis Biotherapeutics Inc's operating cash flow increased by 94.98% year over year.

What is investing cash flow?



Investing cash flow shows cash used for or generated from investment-related activities, such as capital expenditures, purchases or sales of investments, acquisitions, and asset disposals. Negative investing cash flow is not always bad, because it can reflect spending on future growth, but investors should check whether those investments support long-term returns.

How Much Does Arcutis Biotherapeutics Inc Spend on Capital Expenditures?



Arcutis Biotherapeutics Inc spent 10.69M on capital expenditures in the most recent quarter。

What is financing cash flow?



Financing cash flow shows how a company raises capital or returns capital to investors and creditors. It can include debt issuance, debt repayment, share issuance, share repurchases, dividend payments, and lease financing. Positive financing cash flow may show new capital raised, while negative financing cash flow may reflect debt repayment, dividends, or buybacks.

How Has Arcutis Biotherapeutics Inc's Financing Cash Flow Changed?



Arcutis Biotherapeutics Inc used 6.97M in financing activities in the latest quarter.

What is free cash flow and why does it matter for ARQT?



Free cash flow is the cash a company has left after funding the capital spending needed to maintain or grow the business. It is often used to assess financial flexibility, debt repayment capacity, dividend sustainability, buyback potential, and valuation quality. Investors should compare free cash flow with net income, revenue growth, and capital expenditures.

What was Arcutis Biotherapeutics Inc’s free cash flow in the latest quarter?



Free cash flow was -16.31M reflecting a 86.09% change from the previous year.